Healthcare Realty Trust Stock Price Target and Analyst Ratings (NYSE:HR)

Analyst Price Target for HR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$32.13

▼ -1.31% Downside Potential

This price target is based on 8 analysts offering 12 month price targets for Healthcare Realty Trust in the last 3 months. The average price target is $32.13, with a high forecast of $35.00 and a low forecast of $30.00. The average price target represents a -1.31% upside from the last price of $32.55.

Buy

The current consensus among 8 investment analysts is to buy stock in Healthcare Realty Trust. This rating has held steady since July 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

1 strong buy ratings
2 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

10/29/2019

1 strong buy ratings
4 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

1/27/2020

1 strong buy ratings
4 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

4/26/2020

1 strong buy ratings
4 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

7/25/2020

1 strong buy ratings
3 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

10/23/2020

1 strong buy ratings
4 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

1/21/2021

1 strong buy ratings
3 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

3/22/2021

1 strong buy ratings
3 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

4/21/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
3/31/2021	Wells Fargo & Company	Boost Price Target	Equal Weight	$29.00 ➝ $31.00	High	i
3/22/2021	Morgan Stanley	Boost Price Target	Equal Weight	$30.00 ➝ $31.00	Medium	i
3/15/2021	Morgan Stanley	Boost Price Target	Equal Weight	$30.00 ➝ $31.00	High	i
1/28/2021	Scotiabank	Initiated Coverage	Sector Perform	$32.00	Medium	i
1/13/2021	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$30.00 ➝ $33.00	High	i
9/18/2020	Capital One Financial	Upgrade	Equal Weight ➝ Overweight	$33.00	High	i Rating by D. Bernstein at Capital One Financial Co.
9/1/2020	Stifel Nicolaus	Reiterated Rating	Buy	$32.00	Medium	i
8/31/2020	Raymond James	Upgrade	Outperform ➝ Strong-Buy	$34.00 ➝ $35.00	Low	i
8/5/2020	Capital One Financial	Reiterated Rating	Equal Weight		Low	i Rating by D. Bernstein at Capital One Financial Co.
7/2/2020	Citigroup	Boost Price Target	Neutral	$29.00 ➝ $30.00	Low	i Rating by Michael Bilerman at Citigroup Inc.
4/29/2020	Raymond James	Lower Price Target	Outperform	$38.00 ➝ $34.00	High	i
4/28/2020	Wells Fargo & Company	Reiterated Rating	Hold		High	i
4/7/2020	Citigroup	Downgrade	Buy ➝ Neutral	$38.00 ➝ $29.00	High	i Rating by Michael Bilerman at Citigroup Inc.
4/3/2020	Wells Fargo & Company	Lower Price Target	Equal Weight	$33.00 ➝ $26.00	Low	i
4/3/2020	JPMorgan Chase & Co.	Lower Price Target	Neutral	$35.00 ➝ $30.00	Low	i
3/26/2020	Morgan Stanley	Lower Price Target	Equal Weight	$33.00 ➝ $25.00	High	i
3/12/2020	Raymond James	Boost Price Target	Outperform	$36.00 ➝ $38.00	High	i
3/9/2020	BMO Capital Markets	Upgrade	Market Perform ➝ Outperform	$35.00 ➝ $43.00	High	i
2/13/2020	BMO Capital Markets	Reiterated Rating	Hold	$35.00	Low	i
12/20/2019	Mizuho	Reiterated Rating	Neutral	$34.00	Medium	i
12/12/2019	Citigroup	Upgrade	Neutral ➝ Buy	$34.00 ➝ $38.00	Medium	i Rating by Nicholas Joseph at Citigroup Inc.
11/26/2019	Stifel Nicolaus	Upgrade	Hold ➝ Buy	$33.00 ➝ $35.00	High	i
11/6/2019	BMO Capital Markets	Reiterated Rating	Hold	$31.00	Low	i
9/17/2019	Morgan Stanley	Boost Price Target	Equal Weight	$31.00 ➝ $33.00	Low	i Rating by Vikram Malhorta at Morgan Stanley
9/12/2019	Berenberg Bank	Initiated Coverage	Buy		Low	i
8/1/2019	Capital One Financial	Reiterated Rating	Equal Weight		Low	i Rating by D. Bernstein at Capital One Financial Co.
6/20/2019	Citigroup	Initiated Coverage	Neutral ➝ Neutral	$34.00	Low	i
5/13/2019	Raymond James	Upgrade	Mkt Perform ➝ Outperform	$34.00	Medium	i
3/28/2019	Morgan Stanley	Set Price Target	Hold	$31.00	Medium	i Rating by Vikram Malhorta at Morgan Stanley
1/8/2019	Raymond James	Upgrade	Underperform ➝ Market Perform		High	i
12/11/2018	Wells Fargo & Company	Downgrade	Outperform ➝ Market Perform		Medium	i
11/13/2018	Mizuho	Upgrade	Neutral ➝ Buy	$32.00	Low	i
10/18/2018	Raymond James	Initiated Coverage	Underperform ➝ Underperform		Low	i
8/16/2018	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$29.00 ➝ $28.00	High	i
8/13/2018	Mizuho	Reiterated Rating	Hold	$28.00	Low	i Rating by Richard Anderson at Mizuho
6/28/2018	Capital One Financial	Initiated Coverage	Equal Weight	$30.00	Low	i Rating by D. Bernstein at Capital One Financial Co.
6/14/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$32.00 ➝ $29.00	Low	i
4/24/2018	Stifel Nicolaus	Downgrade	Buy ➝ Hold	$30.00 ➝ $28.00	High	i
4/2/2018	Mizuho	Reiterated Rating	Hold	$27.00	Medium	i
3/27/2018	BMO Capital Markets	Reiterated Rating	Hold	$31.00	Low	i Rating by John Kim at BMO Capital Markets
3/20/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$35.00 ➝ $32.00	High	i
3/16/2018	Cantor Fitzgerald	Lower Price Target	Overweight	$34.00	Low	i
2/23/2018	Mizuho	Reiterated Rating	Hold	$29.00	Low	i
2/16/2018	BMO Capital Markets	Reiterated Rating	Hold	$32.00	Medium	i
2/15/2018	SunTrust Banks	Set Price Target	Hold	$30.00	Low	i Rating by Eric Fleming at SunTrust Banks, Inc.
2/15/2018	Stifel Nicolaus	Lower Price Target	Buy ➝ Buy	$34.00 ➝ $30.00	Low	i
2/14/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$38.00	Low	i
1/22/2018	SunTrust Banks	Set Price Target	Hold	$32.00	Low	i Rating by Eric Fleming at SunTrust Banks, Inc.
1/9/2018	BMO Capital Markets	Downgrade	Outperform ➝ Market Perform	$33.00	N/A	i
12/22/2017	KeyCorp	Reiterated Rating	Equal Weight		Low	i Rating by Jordan Sadler at KeyCorp
12/14/2017	Morgan Stanley	Reiterated Rating	Overweight	$34.00	Low	i
11/5/2017	Mizuho	Reiterated Rating	Hold	$34.00	N/A	i
11/3/2017	Stifel Nicolaus	Reiterated Rating	Buy	$34.00	N/A	i
11/2/2017	BMO Capital Markets	Reiterated Rating	Buy	$34.00	N/A	i
10/29/2017	KeyCorp	Set Price Target	Sell	$25.00	N/A	i
10/27/2017	Mizuho	Reiterated Rating	Hold	$35.00	N/A	i
10/2/2017	BMO Capital Markets	Reiterated Rating	Buy	$34.00	Low	i
9/26/2017	KeyCorp	Reiterated Rating	Sell	$25.00	Low	i
9/25/2017	Morgan Stanley	Boost Price Target	Overweight	$32.50 ➝ $34.00	Low	i
8/24/2017	KeyCorp	Reiterated Rating	Sell	$25.00	Low	i
8/23/2017	Cantor Fitzgerald	Reiterated Rating	Buy		Low	i
8/15/2017	Cantor Fitzgerald	Reiterated Rating	Buy	$38.00	Low	i
8/10/2017	Jefferies Financial Group	Reiterated Rating	Hold	$36.00 ➝ $34.00	Low	i
8/4/2017	Stifel Nicolaus	Reiterated Rating	Buy		Low	i
7/17/2017	Jefferies Financial Group	Reiterated Rating	Hold	$36.00	Low	i
6/28/2017	Mizuho	Reiterated Rating	Neutral		Low	i
6/15/2017	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$36.00	Low	i
6/12/2017	Cantor Fitzgerald	Boost Price Target	Buy	$35.00 ➝ $38.00	Medium	i
5/12/2017	Jefferies Financial Group	Reiterated Rating	Buy	$36.00	Medium	i
5/9/2017	Stifel Nicolaus	Lower Price Target	Buy	$34.00 ➝ $33.00	Low	i
3/15/2017	BMO Capital Markets	Upgrade	Market Perform ➝ Outperform	$31.00 ➝ $33.00	High	i
2/20/2017	Desjardins	Reiterated Rating	Buy		N/A	i Rating by M. Markidis at Desjardins
1/31/2017	Cantor Fitzgerald	Upgrade	Hold ➝ Buy		N/A	i
12/22/2016	BMO Capital Markets	Initiated Coverage	Market Perform	$31.00	N/A	i
12/21/2016	KeyCorp	Downgrade	Underweight		N/A	i
12/16/2016	Jefferies Financial Group	Initiated Coverage	Buy		N/A	i
12/15/2016	KeyCorp	Downgrade	Sector Weight ➝ Underweight		N/A	i
12/13/2016	Wells Fargo & Company	Upgrade	Market Perform ➝ Outperform		N/A	i
11/30/2016	Cantor Fitzgerald	Reiterated Rating	Buy	$35.00	N/A	i Rating by Joseph France at Cantor Fitzgerald
11/14/2016	Cantor Fitzgerald	Upgrade	Hold ➝ Buy	$37.00 ➝ $35.00	N/A	i Rating by Joseph France at Cantor Fitzgerald
11/4/2016	JMP Securities	Upgrade	Underperform ➝ Market Perform		N/A	i
9/9/2016	Cantor Fitzgerald	Reiterated Rating	Hold		N/A	i Rating by Joseph France at Cantor Fitzgerald
9/4/2016	Wells Fargo & Company	Reiterated Rating	Hold		N/A	i
8/25/2016	BTIG Research	Initiated Coverage	Neutral		N/A	i
8/22/2016	Royal Bank of Canada	Reiterated Rating	Hold		N/A	i
8/8/2016	Mizuho	Boost Price Target	Neutral	$29.00 ➝ $34.00	N/A	i
8/4/2016	Stifel Nicolaus	Boost Price Target	Buy	$34.00 ➝ $36.00	N/A	i
6/23/2016	Cantor Fitzgerald	Initiated Coverage	Hold	$37.00	N/A	i Rating by Sahar Wolff at Cantor Fitzgerald
6/22/2016	JMP Securities	Downgrade	Market Perform ➝ Underperform	$29.00	N/A	i
5/5/2016	Stifel Nicolaus	Boost Price Target	Buy	$31.00 ➝ $34.00	N/A	i Rating by Daniel Bernstein at Stifel Nicolaus

(Data available from 4/21/2016 forward)

Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September 30, 2020, the Company owned 211 real estate properties in 24 states totaling 15.5 million square feet and was valued at approximately $5.5 billion. The Company provided leasing and property management services to 11.9 million square feet nationwide.

Today's Range

Now: $32.55

$31.62

$32.67

50 Day Range

MA: $30.54

$28.91

$31.65

52 Week Range

Now: $32.55

$26.77

$34.01

Volume

962,171 shs

Average Volume

958,959 shs

Market Capitalization

$4.60 billion

P/E Ratio

38.29

Dividend Yield

3.82%

Beta

0.55

Frequently Asked Questions

What sell-side analysts currently cover shares of Healthcare Realty Trust?

The following Wall Street analysts have issued research reports on Healthcare Realty Trust in the last twelve months: Capital One Financial Co., Citigroup Inc., Jefferies Financial Group Inc., Morgan Stanley, Raymond James, Scotiabank, Stifel Nicolaus, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for HR.

What is the current price target for Healthcare Realty Trust?

8 Wall Street analysts have set twelve-month price targets for Healthcare Realty Trust in the last year. Their average twelve-month price target is $32.13, suggesting a possible downside of 1.3%. Raymond James has the highest price target set, predicting HR will reach $35.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $30.00 for Healthcare Realty Trust in the next year.
View the latest price targets for HR.

What is the current consensus analyst rating for Healthcare Realty Trust?

Healthcare Realty Trust currently has 4 hold ratings, 3 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HR will outperform the market and that investors should add to their positions of Healthcare Realty Trust.
View the latest ratings for HR.

What other companies compete with Healthcare Realty Trust?

Other companies that are similar to Healthcare Realty Trust include American Tower, Public Storage, Welltower, Weyerhaeuser, Ventas, Extra Space Storage, Medical Properties Trust, Omega Healthcare Investors, CubeSmart, Life Storage, Rayonier, Ryman Hospitality Properties, PotlatchDeltic, Sabra Health Care REIT and EPR Properties.

How do I contact Healthcare Realty Trust's investor relations team?

Healthcare Realty Trust's physical mailing address is 3310 WEST END AVE SUITE 700, NASHVILLE TN, 37203. The real estate investment trust's listed phone number is 615-269-8175 and its investor relations email address is [email protected] The official website for Healthcare Realty Trust is www.healthcarerealty.com.

NYSE:HR - Healthcare Realty Trust Stock Price Target and Predictions

Analyst Price Target for HR

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Healthcare Realty Trust?

What is the current price target for Healthcare Realty Trust?

What is the current consensus analyst rating for Healthcare Realty Trust?

What other companies compete with Healthcare Realty Trust?

How do I contact Healthcare Realty Trust's investor relations team?